Chemomab Therapeutics所有资讯

Chemomab Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-Adi Mor(4.8%),Kobi George(4.8%)

11/29 15:09 (美东)

Chemomab Therapeutics | SC 13G：超过5%持股股东披露文件-Erik Otto(6.1%)

11/21 11:05 (美东)

Chemomab Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-OrbiMed Israel BioFund GP Limited Partnership(9.99%),OrbiMed Israel GP Ltd.(9.99%)等

09/16 16:37 (美东)

Chemomab Therapeutics | SC 13G：超过5%持股股东披露文件-Sphera Funds Management Ltd.(6.56%),Sphera Global Healthcare GP Ltd.(6.56%)等

08/20 14:38 (美东)

Chemomab Therapeutics | D：发行公告

08/09 16:43 (美东)

Chemomab Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-OrbiMed Israel BioFund GP Limited Partnership(16.0%),OrbiMed Israel GP Ltd.(16.0%)等

03/11 19:23 (美东)

Chemomab Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-OrbiMed Israel BioFund GP Limited Partnership(18.3%),OrbiMed Israel GP Ltd.(18.3%)等

2023/11/15 16:35 (美东)

Chemomab Therapeutics | 4：持股变动声明-董事 Darvish Nissim

2023/07/05 17:48 (美东)

Chemomab Therapeutics | 4：持股变动声明-董事 Quigley Jill M.

2023/06/20 06:03 (美东)

Chemomab Therapeutics | 4：持股变动声明-首席财务官 Fatal Sigal

2023/06/16 16:03 (美东)

Chemomab Therapeutics | 3：首次持股声明-首席财务官 Fatal Sigal

2023/06/05 16:54 (美东)

Chemomab Therapeutics | 4：持股变动声明-董事 Moses Alan Charles

2023/03/23 07:38 (美东)

Chemomab Therapeutics | 4：持股变动声明-董事 Nicaise Claude

2023/03/23 07:36 (美东)

Chemomab Therapeutics | 4：持股变动声明-董事 Cohen Neil Harris

2023/03/23 07:35 (美东)

Chemomab Therapeutics | 4：持股变动声明-董事 Darvish Nissim

2023/03/23 07:33 (美东)

Chemomab Therapeutics | 4：持股变动声明

2023/01/05 16:49 (美东)

Chemomab Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-OrbiMed Israel BioFund GP Limited Partnership(19.7%),OrbiMed Israel GP Ltd.(19.7%)

2023/01/05 16:31 (美东)

Chemomab Therapeutics | 4：持股变动声明

2023/01/05 16:01 (美东)

Chemomab Therapeutics | 4：持股变动声明

2022/11/18 07:53 (美东)

Chemomab Therapeutics | 4：持股变动声明

2022/11/17 16:56 (美东)